Advanced Cell Technology OTC:ACTC & Geron Corp. NASDAQ:GERN [COLOR=black][FONT=Calibri] A David & Goliath comparison:
On February 23, 2011, Advanced Cell Technology, Inc. (ACT; OTCBB: ACTC) was awarded Patent Number 7,893,315 "single blastomere" technique. ACT's proprietary single blastomere technology provides a non-destructive alternative for deriving hESC lines. What does this mean in plain English? Imagine the smallest blood transfusion in the history of modern medicine. It would be kin to a blood transfusion on a cellular-microscopic level with a two-day old embryo ...
Friends, this is not a Republican and or Democrat matter anymore and IMO we need to remove such debate going forward. 90% of Americans want hESC to be used to save a friend, family member, child or a person whom they do not know. hESC will reshape the Medical health care model that has fed Big Pharmaceutical’s for 50years. No longer will a person needing a heart transplant have to have $800,000 surgery and $50,000 dollars in follow up care. That $800,000 dollars can be ...
Recent Comments